172. 低ホスファターゼ症 Hypophosphatasia Clinical trials / Disease details

臨床試験数 : 34 / 薬物数 : 19 - (DrugBank : 4) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 6

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01406977 (ClinicalTrials.gov)	July 2011	29/7/2011	Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804in Adul ...	An Open-label, Intra-patient Dose-escalation Study to Evaluate the Safety and Tolerability, Pharmaco ...	Hypophosphatasia	Drug: BPS804	Novartis Pharmaceuticals	NULL	Completed	18 Years	70 Years	Both	9	Phase 2	Germany
2	EUCTR2010-024013-31-DE (EUCTR)	30/06/2011	07/02/2011	A clinical study to evaluate the safety and preliminary efficacy of BPS804in adults with hypophospha ...	An open-label, intra-patient dose-escalation study to evaluate the safety and tolerability, pharmaco ...	Hypophosphatasia (HPP) is a rare genetic metabolic disorder which results in impaired skeletal miner ...	Product Name: BPS804 Product Code: BPS804 Other descriptive name: fully human IgG2 lambda monoclonal a ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	9		Germany

First Previous1Next Last